From: Risk and impact of herpes zoster among COPD patients: a population-based study, 2009–2014
Non-COPD | COPD (without ICS) | COPD-ICS | |||||||
---|---|---|---|---|---|---|---|---|---|
Age (years) | Cases | IR | 95% CI | Cases | IR | 95% CI | Cases | IR | 95% CI |
50–59 | 17,907 | 5.3 | 5.3–5.4 | 452 | 7.4 | 6.7–8.1 | 106 | 10.6 | 8.7–12.8 |
60–69 | 19,638 | 7.3 | 7.2–7.4 | 1155 | 10.3 | 9.7–10.9 | 257 | 11.6 | 10.2–13.1 |
70–79 | 16,149 | 8.3 | 8.2–8.4 | 1667 | 12.0 | 11.4–12.6 | 431 | 13.8 | 12.5–15.2 |
≥ 80 | 9951 | 8.6 | 8.5–8.8 | 1355 | 12.8 | 12.1–13.5 | 370 | 14.2 | 12.8–15.7 |
≥ 50 | 63,645 | 7.0 | 6.9–7.0 | 4629 | 11.1 | 10.7–11.4 | 1164 | 13.0 | 12.3–13.8 |
Gender | |||||||||
Male | 23,057 | 5.6 | 5.5–5.7 | 2932 | 10.3 | 10.0–10.7 | 581 | 11.7 | 10.8–12.7 |
Female | 40,588 | 8.1 | 8.0–8.2 | 1697 | 12.6 | 12.0–13.2 | 583 | 14.6 | 13.5–15.9 |
Cases | ReR | 95% CI | Cases | ReR | 95% CI | Cases | ReR | 95% CI | |
≥ 50 | 6396 | 4.2 | 4.1–4.3 | 612 | 5.1 | 4.7–5.1 | 171 | 5.2 | 4.8–5.5 |